FindMyRecallSubscribe
Class II: temporary or reversible health riskTerminated

RemedyRepack Valsartan/HCTZ 320mg/12 Recall

Valsartan/HCTZ 320mg/12

RemedyRepack Inc. · Indiana, PA

Risk level
Class II
Reported by FDA
Aug 8, 2018
Recall ID
D-1021-2018
Check your lot numberHow we source this data

Summary

RemedyRepack recalled Valsartan/HCTZ 320mg/12 starting Jul 17, 2018. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-1021-2018 on Aug 8, 2018. Reason: CGMP Deviations: Carcinogen impurity detected in API used to manufacture drug product. Status: Terminated.

Why it was recalled

CGMP Deviations: Carcinogen impurity detected in API used to manufacture drug product.

Product description

Valsartan/HCTZ 320mg/12.5 mg tablet, 90-count bottle, Rx only, RemedyRepack, 625 Kolter Drive, Suite 4, Indiana, PA 15701

Lot numbers, UPCs & expiration codes

Lot # B0383153-122917; Exp. 12/18

Where it was sold

Product was distributed to 3 medical facilities in Florida.

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-1021-2018
Classification
Class II
Status
Terminated
Recall initiated
Jul 17, 2018
FDA report date
Aug 8, 2018
Quantity
3 HDPE 90-count bottles (270 tablets)
Recall type
Voluntary: Firm initiated
Recalling firm
RemedyRepack Inc.

Original FDA data

Every field from FDA enforcement report D-1021-2018, exactly as published.

Show all FDA fields
City
Indiana
State
PA
Status
Terminated
Country
United States
Event ID
80646
Address
625 Kolter Dr Ste 4
Code information
Lot # B0383153-122917; Exp. 12/18
Postal code
15701-3571
Report date
Aug 8, 2018
Product type
Drugs
Recall number
D-1021-2018
Classification
Class II
Recalling firm
RemedyRepack Inc.
Product quantity
3 HDPE 90-count bottles (270 tablets)
Termination date
Oct 17, 2018
Reason for recall
CGMP Deviations: Carcinogen impurity detected in API used to manufacture drug product.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Valsartan/HCTZ 320mg/12.5 mg tablet, 90-count bottle, Rx only, RemedyRepack, 625 Kolter Drive, Suite 4, Indiana, PA 15701
Distribution pattern
Product was distributed to 3 medical facilities in Florida.
Recall initiation date
Jul 17, 2018
Initial firm notification
Letter
Center classification date
Jul 31, 2018

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-1021-2018, published Aug 8, 2018. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls